VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,134,000 | +46.0% | 350,000 | 0.0% | 0.13% | +42.9% |
| Q1 2018 | $5,572,000 | -82.1% | 350,000 | -76.7% | 0.09% | -87.2% |
| Q4 2017 | $31,170,000 | +0.7% | 1,500,000 | -30.6% | 0.71% | -3.1% |
| Q3 2017 | $30,953,000 | +8.4% | 2,160,000 | +30.9% | 0.74% | +44.9% |
| Q2 2017 | $28,545,000 | +293.2% | 1,650,000 | +230.0% | 0.51% | +202.4% |
| Q4 2016 | $7,260,000 | +253.1% | 500,000 | +5303.1% | 0.17% | +784.2% |
| Q2 2015 | $2,056,000 | -97.6% | 9,254 | -98.5% | 0.02% | -98.0% |
| Q4 2014 | $86,809,000 | +5.6% | 606,587 | -3.2% | 0.95% | +54.4% |
| Q3 2014 | $82,229,000 | +38.1% | 626,748 | +32.7% | 0.61% | +36.7% |
| Q2 2014 | $59,552,000 | +173.1% | 472,187 | +185.5% | 0.45% | +107.9% |
| Q1 2014 | $21,806,000 | – | 165,411 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |